Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

LA GRANDE PHARMACIE DU BOIS DU VERNE : revenue, balance sheet and financial ratios

LA GRANDE PHARMACIE DU BOIS DU VERNE is a French company founded 5 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTCEAU-LES-MINES (71300), this company of category PME shows in 2025 a net income positive of 168 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LA GRANDE PHARMACIE DU BOIS DU VERNE (SIREN 897500674)
Indicator 2025 2024 2023
Revenue N/C N/C N/C
Net income 167 760 € 157 267 € -51 106 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2025, LA GRANDE PHARMACIE DU BOIS DU VERNE generates positive net income of 168 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

167 760 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1328%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1327.568%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

6.022%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

64.7%

Solvency indicators evolution
LA GRANDE PHARMACIE DU BOIS DU VERNE

Sector positioning

Debt ratio
1327.57 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch +50 pts over 3 years

In 2025, the debt ratio of LA GRANDE PHARMACIE DU BO... (1327.57) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
6.02% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch

In 2025, the financial autonomy of LA GRANDE PHARMACIE DU BO... (6.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 230.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

230.18

Liquidity indicators evolution
LA GRANDE PHARMACIE DU BOIS DU VERNE

Sector positioning

Liquidity ratio
230.18 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good +11 pts over 3 years

In 2025, the liquidity ratio of LA GRANDE PHARMACIE DU BO... (230.18) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of LA GRANDE PHARMACIE DU BOIS DU VERNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of LA GRANDE PHARMACIE DU BOIS DU VERNE is estimated at 2 664 887 € (range 1 808 405€ - 4 181 575€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1808k€ 2664k€ 4181k€
2 664 887 € Range: 1 808 405€ - 4 181 575€
NAF 5 année 2025

Valuation method used

Net Income Multiple
167 760 € × 15.9x = 2 664 888 €
Range: 1 808 405€ - 4 181 576€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare LA GRANDE PHARMACIE DU BOIS DU VERNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about LA GRANDE PHARMACIE DU BOIS DU VERNE

What is the revenue of LA GRANDE PHARMACIE DU BOIS DU VERNE ?

The revenue of LA GRANDE PHARMACIE DU BOIS DU VERNE is not publicly disclosed (confidential accounts filed with INPI).

Is LA GRANDE PHARMACIE DU BOIS DU VERNE profitable?

Yes, LA GRANDE PHARMACIE DU BOIS DU VERNE generated a net profit of 168 k€ in 2025.

Where is the headquarters of LA GRANDE PHARMACIE DU BOIS DU VERNE ?

The headquarters of LA GRANDE PHARMACIE DU BOIS DU VERNE is located in MONTCEAU-LES-MINES (71300), in the department Saone-et-Loire.

Where to find the tax return of LA GRANDE PHARMACIE DU BOIS DU VERNE ?

The tax return of LA GRANDE PHARMACIE DU BOIS DU VERNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LA GRANDE PHARMACIE DU BOIS DU VERNE operate?

LA GRANDE PHARMACIE DU BOIS DU VERNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.